UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 461

Sortiert nach

P0817 : Cost-effectiveness of treating chronic hepatitis C genotype-1 with ledipasvir and sofosbuvir in Germany

Journal of hepatology, 2015-04, Vol.62, p.S642-S643

2015

Volltextzugriff (PDF)

Costs of a guideline-based treatment of patients with chronic hepatitis C in the era of interferon-free treatment

Zeitschrift fur Gastroenterologie, 2016-08, Vol.54 (8), p.760

2016

Volltextzugriff (PDF)

Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial

Journal of viral hepatitis, 2016-02, Vol.23 (2), p.105-115

2016

Volltextzugriff (PDF)

A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study

Journal of thrombosis and haemostasis, 2010-06, Vol.8 (6), p.1209-1215

2010

Volltextzugriff (PDF)

Usefullness of ARFI for the Detection of Liver Damage in Routine Ultrasound

Ultrasound in medicine & biology, 2011, Vol.37 (8), p.S13-S14

2011

Volltextzugriff (PDF)

Chronic HCV infections. A model disease for therapy, economics and social-medical aspects

Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)), 2007-03, Vol.69 (3), p.146

Rossol, S

2007

Volltextzugriff (PDF)

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries

Journal of neurology, neurosurgery and psychiatry, 2001-04, Vol.70 (4), p.534-537

2001

Volltextzugriff (PDF)

Costs of a guideline-based treatment of patients with chronic hepatitis C in Germany

Zeitschrift fur Gastroenterologie, 2014-09, Vol.52 (9), p.1041

2014

Volltextzugriff (PDF)

P1147 OUTCOMES AND COSTS OF TREATING HEPATITIS C WITH PROTEASE INHIBITORS: RESULTS FROM A MULTI-CENTRE STUDY

Journal of hepatology, 2014-04, Vol.60 (1), p.S464-S465

2014

Volltextzugriff (PDF)

Cost of illness of hepatitis c in germany: A retrospective multicenter analysis

Value in health, 2013-05, Vol.16 (3), p.A86-A86

2013

Volltextzugriff (PDF)

Butyrate modulates intestinal epithelial cell‐mediated neutrophil migration

Clinical and experimental immunology, 2003-01, Vol.131 (1), p.53-60

2003

Volltextzugriff (PDF)

797 HIGH PREVALENCE OF CHRONIC HEPATITIS C IN 8009 PATIENTS WITH MIGRATION BACKGROUND LIVING IN GERMANY

Journal of hepatology, 2013-04, Vol.58, p.S325-S325

2013

Volltextzugriff (PDF)

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

The Journal of clinical investigation, 1997-06, Vol.99 (12), p.3025-3033

1997

Volltextzugriff (PDF)

PIN38 Guideline Evaluation of Costs Related to Chronic Hepatitis C and Antiviral Treatment Strategies

Value in health, 2011, Vol.14 (7), p.A272-A272

2011

Volltextzugriff (PDF)

Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial

Value in health, 2013-11, Vol.16 (7), p.A341-A342

2013

Volltextzugriff (PDF)

Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases

Neurology, 1999-09, Vol.53 (5), p.1104

1999

Volltextzugriff (PDF)

EE566 Cost-Effectiveness and Budget Impact Analysis of Selective Internal Radiation Therapy Versus Atezolizumab Plus Bevacizumab From a German Statutory Health Insurance Perspective

Value in health, 2022-12, Vol.25 (12), p.S167-S167

2022

Volltextzugriff (PDF)

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

Gut, 1999-03, Vol.44 (3), p.424-429

1999

Volltextzugriff (PDF)

Increased release of interleukin-12p40 in MS: association with intracerebral inflammation

Neurology, 1998-09, Vol.51 (3), p.753

1998

Volltextzugriff (PDF)

Kinetics of soluble tumour necrosis factor (TNF)‐α receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)‐α alone, IFN‐α plus amantadine or plus ribavirin

Clinical and experimental immunology, 2004-06, Vol.136 (3), p.507-512

2004

Volltextzugriff (PDF)

Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection

Clinical and experimental immunology, 1998-02, Vol.111 (2), p.269-277

1998

Volltextzugriff (PDF)

Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective

ClinicoEconomics and outcomes research, 2024-06, Vol.16, p.483-492

2024

Volltextzugriff (PDF)

PRESENCE OF PLASMA ENDOTOXIN IS CORRELATED WITH TUMOUR NECROSIS FACTOR RECEPTOR LEVELS AND DISEASE ACTIVITY IN ALCOHOLIC CIRRHOSIS

Alcohol and alcoholism (Oxford), 1998-11, Vol.33 (6), p.606-608

1998

Volltextzugriff (PDF)

Antiviral treatment initiation costs in chronic hepatitis C

Gut, 2005-01, Vol.54 (1), p.172-173

2005

Volltextzugriff (PDF)

Identification of Nicotinamide N-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer

Clinical cancer research, 2005-09, Vol.11 (18), p.6550-6557

2005

Volltextzugriff (PDF)

1 – 25 von 461

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(390)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(24)
Arthritis And Rheumatism
(12)
Value In Health
(12)
Gastroenterology
(9)
Zeitschrift Für Gastroenterologie
(9)
Journal Of Applied Physics
(8)
German History
(7)
Gut
(7)
Industrial Robot
(7)
Journal Of The American Ceramic Society
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

P0817 : Cost-effectiveness of treating chronic hepatitis C genotype-1 with ledipasvir and sofosbuvir in Germany

Costs of a guideline-based treatment of patients with chronic hepatitis C in the era of interferon-free treatment

Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial

A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study

Usefullness of ARFI for the Detection of Liver Damage in Routine Ultrasound

Chronic HCV infections. A model disease for therapy, economics and social-medical aspects

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries

Costs of a guideline-based treatment of patients with chronic hepatitis C in Germany

P1147 OUTCOMES AND COSTS OF TREATING HEPATITIS C WITH PROTEASE INHIBITORS: RESULTS FROM A MULTI-CENTRE STUDY

Cost of illness of hepatitis c in germany: A retrospective multicenter analysis

Butyrate modulates intestinal epithelial cell‐mediated neutrophil migration

797 HIGH PREVALENCE OF CHRONIC HEPATITIS C IN 8009 PATIENTS WITH MIGRATION BACKGROUND LIVING IN GERMANY

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

PIN38 Guideline Evaluation of Costs Related to Chronic Hepatitis C and Antiviral Treatment Strategies

Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial

Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases

EE566 Cost-Effectiveness and Budget Impact Analysis of Selective Internal Radiation Therapy Versus Atezolizumab Plus Bevacizumab From a German Statutory Health Insurance Perspective

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

Increased release of interleukin-12p40 in MS: association with intracerebral inflammation

Kinetics of soluble tumour necrosis factor (TNF)‐α receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)‐α alone, IFN‐α plus amantadine or plus ribavirin

Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection

Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective

PRESENCE OF PLASMA ENDOTOXIN IS CORRELATED WITH TUMOUR NECROSIS FACTOR RECEPTOR LEVELS AND DISEASE ACTIVITY IN ALCOHOLIC CIRRHOSIS

Antiviral treatment initiation costs in chronic hepatitis C

Identification of Nicotinamide N-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer

Suchergebnisse filtern